banner
Bcr-Abl inhibitor PD173955, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ497

Bcr-Abl inhibitor PD173955, Purity ≥98%

Synonym: 260415-63-2; Bcr-Abl inhibitor; PD 173955; PD-173955

  • CAS Number: 260415-63-2
  • Compound CID: 447077
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
PD173955, soluble in warmed DMSO and insoluble in water and ethanol, specifically inhibits the activity of the Bcr-Abl tyrosine kinase. It targets Bcr-Abl and Src.
Molecular Weight
443.35
Molecular Formula
C21H16Cl2N4OS
Targets
Bcr-Abl: 1-2 nM; Src: 22 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 13 mg/mL (29.32 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
PD173955 targets Bcr-Abl, investigated for its efficacy in treating leukemia.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0